Event Details
Thursday, November 13, 2025
5:45pm – 8:30pm ET
*Pre-Registration Required
Live In-Person Event
Interactive continuing medical education activity for healthcare professionals in Philadelphia, New Jersey, Delaware, and surrounding areas to discuss best practices on addressing challenges in managing transplant patients. This case-based symposium will focus on hematologic malignancy patients who are either on the pathway to hematopoietic cell transplant or experiencing disease relapse post-transplant. Through real-world cases, this program will explore evolving therapeutic options, patient selection considerations, and post-transplant care, including collaboration between referring physicians and transplant teams to optimize continuity of care for transplant candidates and recipients.
Hilton Philadelphia City Avenue
4200 City Avenue
Philadelphia,
PA
Target Audience
This activity is intended for hematologists, hematology fellows,
advanced practice providers, and nurses involved in the care of stem cell
transplant patients.
Agenda
5:45 PM – Dinner and Networking
6:30 PM – Overview of Blood Cancer United and NMDP
Resources
Lauren Berger, MPH and Anna Cincotta, MSN, NP
6:40 PM – Keynote Address
Alison W. Loren, MD
6:50 PM-8:20 PM – Case Presentations and Discussions
Case 1: Defining and refining eligibility for allogeneic HCT
Case 2: Multidisciplinary efforts for successful outcomes; leveraging your colleagues
in caring for your patient
Case 3: The road less
traveled- coordinating care for active needs for long term survivors
8:20 PM – Closing remarks
David L. Porter, MD
8:30 PM – Adjourn
Learning Objectives
At the conclusion of this activity, participants will be better able to:
- Analyze complex clinical scenarios involving patients with hematologic malignancies being evaluated for or proceeding to hematopoietic cell transplantation
- Evaluate treatment strategies for managing post-stem cell transplant relapse, incorporating current evidence-based practices and emerging therapies
- Identify clinical and logistical considerations that impact referral timing and patient outcomes during the transplant process
- Enhance interdisciplinary collaboration between referring physicians and transplant teams to optimize continuity of care for transplant candidates and recipients
- Apply insights from real-world case presentations to inform decision-making and improve clinical care in the pre- and post-HCT setting
Advisory group
Pashna N. Munshi, MD (Chair)
Penn Medicine
Philadelphia,
PA
Usama Gergis, MD, MBA
Jefferson Health
Philadelphia,
PA
Mary Ellen Martin, MD, FACP
Penn Medicine
Philadelphia,
PA
Joanne Filicko-O’Hara, MD
Jefferson Health
Philadelphia,
PA
Kara Saggiomo, MSN, APN-C, AOCNP
Cooper Health
Camden,
NJ
Roger Strair, MD, PhD
Cooper Health
Camden, NJ
Michael Styler, MD
Fox Chase Cancer Center
Temple
University
Philadelphia, PA
Alexander Vartanov, MD
Fox Chase Cancer Center
Temple
University
Philadelphia, PA
Faculty
Lauren Berger MPH
Blood Cancer United
Washington,
DC
Anna Cincotta, MSN, NP
NMDP
Minneapolis, MN
Casey Degan, MD
Jefferson Health
Philadelphia, PA
Joanne Filicko-O’Hara, MD
Jefferson Health
Philadelphia,
PA
Usama Gergis, MD, MBA
Jefferson Health
Philadelphia,
PA
Nasheed Hossain, MD
Penn Medicine
Philadelphia, PA
Catherine Lai, MD, MPH
Penn Medicine
Philadelphia,
PA
Cydney Nichols, MD
Penn Medicine
Philadelphia, PA
Anne Ojala, CRNP, AOCNP
Fox Chase Cancer Center
Temple
University
Philadelphia, PA
Alison W. Loren, MD, MSCE
Penn Medicine
Philadelphia,
PA
Linda Perry, PA-C
Penn Medicine
Philadelphia, PA
David L. Porter, MD
Penn Medicine
Philadelphia, PA
Kara Saggiomo, MSN, APN-C, AOCNP
Cooper Health
Camden,
NJ
Roger Strair, MD, PhD
Cooper Health
Camden, NJ
Michael Styler, MD
Fox Chase Cancer Center
Temple
University
Philadelphia, PA
Rachel Thomas, MD
Fox Chase Cancer Center
Temple
University
Philadelphia, PA
Alexander Vartanov, MD
Fox Chase Cancer Center
Temple
University
Philadelphia, PA
Accreditation, Credit and Support
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Penn Medicine designates this live activity for a maximum of
2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent
of their participation in the activity.
Physician Associate
Penn Medicine has been
authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME
credit for activities planned in accordance with the AAPA CME Criteria. This
activity is designated for
2.0 AAPA Category 1 CME credits. PAs should only claim
credit commensurate with the extent of their participation.
Nurses
This activity awards
2.0 NCPD hours.
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form using a link provided in an email that will be sent to you post activity. Once you have completed the evaluation you will be prompted to download your certificate. If you have questions regarding receiving credits, please contact Amanda Barefield ([email protected]).
Providers
This activity is provided by the University of
Pennsylvania in collaboration with The Leukemia & Lymphoma Society,
now Blood Cancer United, and NMDP.
Supporter
Penn Medicine thanks Sanofi for their
financial support.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact Amanda Barefield ([email protected]), Penn Medicine, or Lauren Berger ([email protected]), Blood Cancer United.